NL-OMON24408尚未招募不适用
Prostate Cancer Imaging with [18Flourine]Prostate Specific Membrane Antigen (PSMA) PET-CT: a study on pharmacokinetics and test repeatability
VU University Medical Center, Amsterdam0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Histologically proven prostate cancer, with lymphatic and/or haematogeneous metastases
排除标准
- •Claustrophobia (part A and B)
- •Multiple malignancies (part A and B)
研究者
相似试验
已完成
3 期
Prostate Cancer Imaging with [18Flourine]Prostate Specific Membrane Antigen (PSMA) PET: a study on pharmacokinetics and test repeatabilityprostate malignancyneoplasm of the prostate10038597prostate cancerNL-OMON45317Vrije Universiteit Medisch Centrum20
招募中
不适用
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancerNeoplasmsKCT0003924Korea Cancer Center Hospital6
进行中（未招募）
不适用
Diagnostic imaging in prostate cancer (as in tumours with accelerated menbrane turn-over)by F-18 Fluoro-metil-choline PET/CTpatients with prostate cancer istologically provenMedDRA version: 14.1Level: SOCClassification code 10038359Term: Renal and urinary disordersSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 14.1Level: SOCClassification code 10022891Term: InvestigationsSystem Organ Class: 10022891 - InvestigationsEUCTR2008-003337-24-ITCENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA
招募中
不适用
Evaluation of new PET tracer, [F-18]Florastamin for diagnosing prostate cancer: Phase I clinical trialKCT0004817FutureChem10
招募中
不适用
Imaging of Metastatic Prostate Cancer Tumors Using 68Ga-NTA-14Cancer - ProstateMetastatic Prostate CancerACTRN12621001704886St. Vincent's Hospital Sydney Limited10